Get started
Author

A. Bensalem

Observed names: A Bensalem, ASSIA BENSALEM, Assia A. Bensalem, Assia BENSALEM, Assia BENSALEM, MD, PhD, Assia Bensalem
ORCID: 0000-0002-1591-621X
Observed ORCID: 0000-0002-1591-621X
OpenAlex ID: A5101967768
Impact of the COVID-19 Pandemic on Oncologists: Results of an International Study
2021 · Abdul Rahman Jazieh, Anelisa K. Coutinho, et al. · JCO Global Oncology · 20
PDF
Neoadjuvant endocrine therapy with or without palbociclib in low-risk patients: a phase III randomized double-blind SAFIA trial
2023 · K. Alsaleh, H. Al Zahwahry, et al. · Journal of Cancer Research and Clinical Oncology · 19
PDF
Burnout in oncology: Magnitude, risk factors and screening among professionals from Middle East and North Africa (BOMENA study)
2021 · Atlal Abusanad, Assia Bensalem, et al. · Psycho-Oncology · 17
Prediction of response to neoadjuvant hormonal therapy (NAHT) using upfront oncotype Dx recurrence score (RS): Results from the SAFIA phase III trial.
2020 · Khalid A Al-Saleh, Adda Bounedjar, et al. · Journal of Clinical Oncology · 11
Epidemiology of breast cancer in women based on diagnosis data from oncologists and senologists in Algeria
2020 · F Smaili, A Boudjella, et al. · Cancer Treatment and Research Communications · 11
PDF
Early onset breast cancer: differences in risk factors, tumor phenotype, and genotype between North African and South European women
2017 · Carole Corsini, Sarra Henouda, et al. · Breast Cancer Research and Treatment · 11
Response to Induction Neoadjuvant Hormonal Therapy Using Upfront 21-Gene Breast Recurrence Score Assay—Results From the SAFIA Phase III Trial
2021 · Khalid AlSaleh, Heba Al Zahwahry, et al. · JCO Global Oncology · 9
PDF
Thérapie ciblée et cancer du sein : état de l’art
2012 · D. Molnar-Stanciu, V. Guimas, et al. · Pathologie Biologie · 8
Prevalence and Risk Factors of Burnout Among Female Oncologists From the Middle East and North Africa
2022 · Atlal Abusanad, Assia Bensalem, et al. · Frontiers in Psychology · 7
PDF
Incidence of lung cancer in males and females in Algeria: The lung cancer registry in Algeria (LuCaReAl)
2020 · Adda Bounedjar, Radjâa Benkali, et al. · Cancer Epidemiology · 5
Final result for SAFIA trial for neoadjuvant palbociclib in patients with operable luminal breast cancer responding to fulvestrant.
2022 · Khalid A. Al-Saleh, Heba Mohamed El Zawahry, et al. · Journal of Clinical Oncology · 4
1687P Oncologists knowledge, attitude and practice in COVID-19 pandemic and its negative impact on them: An international study
2020 · A.R. Jazieh, A.K. Coutinho, et al. · Annals of Oncology · 3
PDF
1717P Behavioral practices of cancer patients during COVID-19 pandemic: A Middle East and North Africa Study
2020 · A.R. Jazieh, Z. Benbrahim, et al. · Annals of Oncology · 2
PDF
1579P Burnout among oncology professionals in the Middle East and North Africa (MENA)
2020 · A.M. Abusanad, A. Bensalem, et al. · Annals of Oncology · 2
PDF
Épidémiologie des cancers du sein de la femme jeune en Afrique du Nord
2010 · Yazid Belkacémi, H Boussen, et al. · HAL · 2
Docetaxel plus capecitabine in the treatment of previous anthracycline-treated patients with metastatic breast cancer
2009 · A. Bensalem, K. Bouzid · Journal of Clinical Oncology · 2
Gemcitabine in metastatic breast cancer
2006 · A. Bensalem, K. Bouzid · Journal of Clinical Oncology · 2
A multicentre, international neoadjuvant (NA), randomized, double-blind phase III trial comparing fulvestrant to a combination of fulvestrant and palbociclib in patients with operable luminal breast cancer (SAFIA Trial)
2019 · J-MA Nabholtz, K.A. Alsaleh, et al. · Annals of Oncology · 1
Gemcitabine/paclitaxel compared to gemcitabine/vinorelbine in metastatic breast cancer: An interim analysis
2007 · A. Bensalem, K. Bouzid · Journal of Clinical Oncology · 1
A phase II trial of doxorubicin (DXR) and gemcitabine (GMZ) administered in patients with metastatic breast cancer (MBC)
2005 · A. Bensalem, K. Bouzid · Journal of Clinical Oncology · 1
A phase II randomized trial of doxorubicin (DXR) and gemcitabine (GMZ) administered in patients with metastatic breast cancer (MBC)
2005 · A Bensalem, K Bouzid · Breast Cancer Research · 1
PDF
Gemcitabine (G) and Doxorubicin (DXR) as first-line treatment of metastatic breast cancer (MBC): Preliminary results
2004 · A. Bensalem, K. Bouzid · Journal of Clinical Oncology · 1
Malnutrition as a determinant of impaired quality of life in neuroendocrine tumor patients: A single-center cohort
2026 · ASSIA BENSALEM, Abdelaziz AMMARI, et al.
PDF
Sarcopenia as an independent prognostic factor of reduced survival in elderly pancreatic cancer patients: A single-center experience
2026 · ASSIA BENSALEM, Abdelaziz AMMARI, et al.
PDF
Primary Ovarian Ependymoma: A Diagnostic Challenge Resolved by Immunohistochemistry. A Case Report
2026 · ASSIA BENSALEM, Sihem BENSALEM, et al.
PDF
Works count: 53
Citation count: 140
H-index: 8
I10-index: 6
Year
Topic
Type